adaptive biotechnologies stock analysis
Stay up to date on the latest stock price chart news analysis fundamentals trading and. ADPT has a market cap or net worth of 93153 million as of September 27 2022 making it the 2505th biggest public company in the US.
Should You Buy Adaptive Biotechnologies Corp Adpt Stock On Tuesday
As of the 3rd of April Adaptive Biotechnologies shows the risk adjusted performance of 013 and Mean Deviation of 435.
. Review the latest analysis on Adaptive Biotechnologies Corp 1HMXETR stock to find out if this stock is best investment for you based on Morningstars analysis. ADPT a commercial stage biotechnology company that translates the. Adaptive Biotechnologies technical analysis gives you the.
05 2022 GLOBE NEWSWIRE -- Adaptive Biotechnologies Corporation Nasdaq. Adaptive Biotechnologies Corporation NASDAQADPT traded at 763 at close of the session on Friday 091622 made a. The lowest target is 808 and.
Price as of September 30 2022 300 pm. Exclusive research and insights from bulls and bears. September 19 2022.
Detailed balance sheet for Adaptive Biotechnologies ADPT including cash debt assets liabilities and book value. ADPTs market cap has. The Stock rose vividly during the last.
Adaptive Biotechnologies Stock analysis including Adaptive Biotechnologies investment evaluation stock information alerts predictive tools such as market volatility and liquidity. ADPT Adaptive Biotechnologies - Stock quote performance technical chart analysis SmartSelect Ratings Group Leaders and the latest company headlines. Review the latest analysis on Adaptive Biotechnologies Corp ADPTXNAS stock to find out if this stock is best investment for you based on Morningstars analysis.
See Adaptive Biotechnologies Corporation ADPT stock analyst estimates including earnings and revenue EPS upgrades and downgrades. A high-level overview of Adaptive Biotechnologies Corporation ADPT stock. According to 15 stock analysts the average 12-month stock price forecast for ADPT stock is 1343 which predicts an increase of 8862.
The company has 38618 million in cash and 11134 million in debt giving a net cash position of 27484 million or 192 per share. Adaptive Biotechnologies Stock analysis including Adaptive Biotechnologies investment evaluation stock information alerts predictive tools such as market volatility and liquidity. Lets start up with the current stock price of Adaptive Biotechnologies Corporation ADPT which is 819 to be very precise.
Find the latest Adaptive Biotechnologies Corporation ADPT stock analysis from Seeking Alphas top analysts. Detailed financial statements for Adaptive Biotechnologies ADPT including the income statement balance sheet and cash flow statement. Adaptive Biotechnologies Corporation NASDAQ.
Adaptive Biotechnologies Funding Financials Valuation Investors
Adaptive Biotechnologies Good Buy For Long Term Investors Adpt Seeking Alpha
Billion Dollar Seattle Company Adaptive Biotechnologies Lays Off 100 The Seattle Times
Adaptive Biotechnologies Corporation Stock Value Analysis Nyse Adpt
Adaptive Biotechnologies A Platform Play For Immune Driven Medicine Nasdaq Adpt Seeking Alpha
Adaptive Biotechnologies Corporation Adpt Stock Price Quote News Stock Analysis
Adaptive Biotechnologies Plans To Sell Up To 9 2m Shares Revenue Grew 52 In 2019 Geekwire
Adaptive Biotechnologies Hold Despite Weak Financials As Catalysts Are Ahead Nasdaq Adpt Seeking Alpha
Adaptive Biotechnologies Good Buy For Long Term Investors Adpt Seeking Alpha
S 1
Ihogj5sp Tphjm
S 1
Adpt 10k 20201231 Htm
Adpt Adaptive Biotechnologies Corp Stock Overview U S Nasdaq Barron S
Institutional Owners May Consider Drastic Measures As Adaptive Biotechnologies Corporation S Nasdaq Adpt Recent Us 104m Drop Adds To Long Term Losses
Adpt 10k 20201231 Htm
Here S Why We Re Watching Adaptive Biotechnologies Nasdaq Adpt Cash Burn Situation
Adaptive Biotechnologies Adpt Investor Presentation Slideshow Nasdaq Adpt Seeking Alpha
Adaptive Biotechnologies Adpt Investor Presentation Slideshow Nasdaq Adpt Seeking Alpha